Chemoinformaics analysis of Thujopsadiene
Molecular Weight | 202.341 | nRot | 0 |
Heavy Atom Molecular Weight | 180.165 | nRig | 13 |
Exact Molecular Weight | 202.172 | nRing | 3 |
Solubility: LogS | -5.29 | nHRing | 0 |
Solubility: LogP | 4.958 | No. of Aliphatic Rings | 3 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 3 |
Atoms Count | 37 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 0 |
nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 1 |
No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 15 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
nHA | 0 | APOL | 39.7194 |
nHD | 0 | BPOL | 22.0706 |
QED | 0.513 |
Synth | 5.299 |
Natural Product Likeliness | 2.908 |
NR-PPAR-gamma | 0.011 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0 |
Pgp-sub | 0 |
HIA | 0.007 |
CACO-2 | -4.371 |
MDCK | 0.000016 |
BBB | 0.177 |
PPB | 0.926662 |
VDSS | 2.231 |
FU | 0.0960403 |
CYP1A2-inh | 0.599 |
CYP1A2-sub | 0.653 |
CYP2c19-inh | 0.517 |
CYP2c19-sub | 0.918 |
CYP2c9-inh | 0.348 |
CYP2c9-sub | 0.822 |
CYP2d6-inh | 0.149 |
CYP2d6-sub | 0.849 |
CYP3a4-inh | 0.555 |
CYP3a4-sub | 0.331 |
CL | 13.188 |
T12 | 0.049 |
hERG | 0.016 |
Ames | 0.014 |
ROA | 0.1 |
SkinSen | 0.401 |
Carcinogencity | 0.847 |
EI | 0.744 |
Respiratory | 0.49 |
NR-Aromatase | 0.334 |
Antiviral | Yes |
Prediction | 0.865764 |